COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

Seasonal maternal respiratory syncytial virus vaccination and nirsevimab for infants demonstrate cost-effectiveness.

RSV remains a major cause of hospitalization among children, according to a population-based Canadian Immunization Research ...

Experts worry that the unenthusiastic embrace of vaccines could spark outbreaks and increased hospitalizations.

"Flu tends to impact us a little later in the year, or early into the new year, so that at this point in time for any of the ...

COLUMBIA - The start of winter is less than a month away, and as temperatures continue to decline cases of the flu and ...

Three scientists received the Tata Transformation Prize for innovations in sustainable energy, nutrition, and a low-cost RSV vaccine, each winning ₹2 crore ...

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe ...

it is also important to talk with your doctor and stay up to date on vaccines for pneumococcal disease, flu, RSV, and COVID-19. PNEUMOCOCCAL DISEASEPneumococcal disease is caused by bacteria that ...

Respiratory viruses like COVID-19 spread more effectively in colder temperatures, putting younger children and older adults ...

CDC expects hospitalizations for flu and COVID-19 to start increasing in the coming weeks. It also sees increased RSV ...

Respiratory syncytial virus (RSV) is associated with a considerable burden of hospitalizations, intensive care unit (I ...